154 related articles for article (PubMed ID: 15910860)
1. Enhanced RAGE-mediated NFkappaB stimulation in inflamed hemodialysis patients.
Rodríguez-Ayala E; Anderstam B; Suliman ME; Seeberger A; Heimbürger O; Lindholm B; Stenvinkel P
Atherosclerosis; 2005 Jun; 180(2):333-40. PubMed ID: 15910860
[TBL] [Abstract][Full Text] [Related]
2. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis.
El-Saeed GS; Fadel F; Elshamaa MF; Galal RE; Elghoroury EA; Nasr SA; Thabet EH; Abdelrahman SM
Ren Fail; 2015; 37(9):1452-6. PubMed ID: 26337710
[TBL] [Abstract][Full Text] [Related]
5. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
[TBL] [Abstract][Full Text] [Related]
6. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
Ng ZX; Kuppusamy UR; Iqbal T; Chua KH
Gene; 2013 Jun; 521(2):227-33. PubMed ID: 23545311
[TBL] [Abstract][Full Text] [Related]
7. [Activation of receptor for advanced glycation end products: a mechanism for monocyte-mediated inflammation in chronic renal failure].
Hou FF; Ren H; Guo ZJ; Chen PY; Liang M; Zhang X
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1614-9. PubMed ID: 15569456
[TBL] [Abstract][Full Text] [Related]
8. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
9. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
Sebeková K; Podracká L; Heidland A; Schinzel R
Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
[TBL] [Abstract][Full Text] [Related]
10. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
11. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
[TBL] [Abstract][Full Text] [Related]
12. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
13. The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study.
Meertens JH; Nienhuis HL; Lefrandt JD; Schalkwijk CG; Nyyssönen K; Ligtenberg JJ; Smit AJ; Zijlstra JG; Mulder DJ
PLoS One; 2016; 11(8):e0160893. PubMed ID: 27529340
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products and mortality in hemodialysis patients.
Schwedler SB; Metzger T; Schinzel R; Wanner C
Kidney Int; 2002 Jul; 62(1):301-10. PubMed ID: 12081592
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products-induced apoptosis attenuated by PPARdelta activation and epigallocatechin gallate through NF-kappaB pathway in human embryonic kidney cells and human mesangial cells.
Liang YJ; Jian JH; Liu YC; Juang SJ; Shyu KG; Lai LP; Wang BW; Leu JG
Diabetes Metab Res Rev; 2010 Jul; 26(5):406-16. PubMed ID: 20583309
[TBL] [Abstract][Full Text] [Related]
16. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
[TBL] [Abstract][Full Text] [Related]
17. Ischemia-modified albumin (IMA) is increased in patients with chronic hepatitis C infection and related to markers of oxidative stress and inflammation.
Zuwała-Jagiełło J; Warwas M; Pazgan-Simon M
Acta Biochim Pol; 2012; 59(4):661-7. PubMed ID: 23227456
[TBL] [Abstract][Full Text] [Related]
18. Protein oxidative stress and dyslipidemia in dialysis patients.
Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
[TBL] [Abstract][Full Text] [Related]
19. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
20. Posttranslationally modified proteins as mediators of sustained intestinal inflammation.
Andrassy M; Igwe J; Autschbach F; Volz C; Remppis A; Neurath MF; Schleicher E; Humpert PM; Wendt T; Liliensiek B; Morcos M; Schiekofer S; Thiele K; Chen J; Kientsch-Engel R; Schmidt AM; Stremmel W; Stern DM; Katus HA; Nawroth PP; Bierhaus A
Am J Pathol; 2006 Oct; 169(4):1223-37. PubMed ID: 17003481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
